Skip to main content
. 2019 Dec 2;9(12):e033131. doi: 10.1136/bmjopen-2019-033131

Figure 1.

Figure 1

Study schedule of the iDReAM (Induced pluripotent stem cell–based Drug Repurposing for Amyotrophic lateral sclerosis Medicine) study.